Clinical Trial Update: IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing IVIG to plasmapheresis in Guillain-Barré Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome

Drugs mentioned

• IVIG (intravenous immunoglobulin)
• plasmapheresis

Snippet

Sponsor: Assiut University | Conditions: Guillain-Barre Syndrome | Phase 2, Phase 3 | Status: COMPLETED